Esperion Therapeutics Inc
🇨🇷Costa Rica
- Country
- 🇨🇷Costa Rica
- Ownership
- Public
- Established
- 1998-01-01
- Employees
- 240
- Market Cap
- $335.5M
- Website
- http://www.esperion.com
A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes
- First Posted Date
- 2012-05-30
- Last Posted Date
- 2019-03-29
- Lead Sponsor
- Esperion Therapeutics, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT01607294
A Multiple Ascending Dose Study of ETC-1002 in Healthy Subjects
- First Posted Date
- 2011-12-05
- Last Posted Date
- 2019-03-28
- Lead Sponsor
- Esperion Therapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01485146
- Locations
- 🇺🇸
Jasper Clinic, Inc., Kalamazoo, Michigan, United States
A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides
- First Posted Date
- 2010-12-17
- Last Posted Date
- 2021-03-17
- Lead Sponsor
- Esperion Therapeutics, Inc.
- Target Recruit Count
- 177
- Registration Number
- NCT01262638
A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia
- First Posted Date
- 2010-04-16
- Last Posted Date
- 2019-03-28
- Lead Sponsor
- Esperion Therapeutics, Inc.
- Target Recruit Count
- 53
- Registration Number
- NCT01105598
- Locations
- 🇺🇸
Jasper Clinic, Inc., Kalamazoo, Michigan, United States
© Copyright 2024. All Rights Reserved by MedPath